首頁 > 市場調查報告書 > 製藥

藥物開發臨床實驗開發業務受託機關

市場調查報告書

商品編碼

2050498

臨床前CRO市場：按服務、類型、動物模型、模型系統、應用、最終用戶和地區分類

Preclinical CRO Market, By Service, By Type, By Animal Model, By Model System, By Application, By End Users, By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年臨床前CRO市場規模估計為74億美元，預計2033年將達到134.9億美元。預計2026年至2033年，該市場將以9.0%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	74億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.00%	2033年市場規模預測：	134.9億美元

近年來，受製藥和生物技術公司對臨床前研究外包需求的不斷成長的推動，全球臨床前CRO市場經歷了顯著成長。臨床前CRO（合約研究組織）在藥物發現和開發過程中發揮著至關重要的作用，提供包括毒性測試、藥物動力學和動態研究以及動物模型開發在內的廣泛服務。這些機構有助於簡化藥物開發的臨床前階段，使製藥公司能夠專注於其核心競爭力，並更快地將新治療方法推向市場。臨床前CRO市場競爭激烈，多家全球領導者提供專業服務和先進技術，以滿足不斷變化的客戶需求。隨著製藥業持續面臨研發成本上升和監管審查日益嚴格等挑戰，預計未來幾年對臨床前CRO服務的需求將進一步成長。

市場動態：

全球臨床前CRO市場受多種因素驅動，包括製藥和生技公司擴大將臨床前研究活動外包、對專業臨床前服務的需求不斷成長，以及降低藥物研發成本和縮短研發週期的必要性。透過將臨床前試驗外包給CRO，企業無需投入大量資金即可獲得專業知識、先進技術和一流的設施。此外，藥物研發日益複雜，加上必須遵守嚴格的監管要求，進一步推動了對臨床前CRO服務的需求。然而，臨床前試驗高成本、熟練專業人員短缺以及資料安全和智慧財產權保護方面的挑戰等因素可能會抑制市場成長。儘管有這些挑戰，臨床前CRO市場仍蘊藏著巨大的成長機會。這主要得益於3D細胞培養、晶片器官和In Silico模擬等先進技術的日益普及，這些技術有助於提高臨床前試驗的預測準確性和效率。此外，對個人化醫療的需求不斷成長，以及對罕見疾病和孤兒藥的日益關注，預計將在未來幾年為臨床前合約研究組織創造新的機會。

本研究的主要特點：

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球非臨床 CRO 市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球臨床前 CRO 市場報告的目標對象包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
透過分析全球臨床前 CRO 市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第11章競爭格局

Charles River Laboratories
Covance（Labcorp）
WuXi AppTec
ICON plc
PPD（Part of Thermo Fisher Scientific）
Medpace
Evotec SE
Syneos Health
BioReliance（Merck KGaA）
Charles River
KCR
Parexel International
Inotiv
Toxikon
Harlan Laboratories

第12章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第13章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI7886

Preclinical CRO Market is estimated to be valued at USD 7.40 Bn in 2026 and is expected to reach USD 13.49 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 7.40 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.00%	2033 Value Projection:	USD 13.49 Bn

The global preclinical CRO market has witnessed significant growth in recent years, driven by the increasing demand for outsourcing preclinical research activities by pharmaceutical and biotechnology companies. Preclinical Contract Research Organizations (CROs) play a crucial role in the drug discovery and development process, providing a wide range of services such as toxicology testing, pharmacokinetic and pharmacodynamic studies, and animal model development. These organizations help streamline the preclinical phase of drug development, enabling pharmaceutical companies to focus on their core competencies and accelerate the delivery of new therapies to the market. The preclinical CRO market is highly competitive, with several key players operating globally, offering specialized services and advanced technologies to meet the evolving needs of their clients. As the pharmaceutical industry continues to face challenges such as rising research and development costs and increasing regulatory scrutiny, the demand for preclinical CRO services is expected to grow further in the coming years.

Market Dynamics:

The global preclinical CRO market is driven by several factors, including the increasing outsourcing of preclinical research activities by pharmaceutical and biotechnology companies, the growing demand for specialized preclinical services, and the need to reduce drug development costs and timelines. Outsourcing preclinical studies to CROs allows companies to access specialized expertise, advanced technologies, and state-of-the-art facilities, without the need for significant capital investments. Additionally, the increasing complexity of drug development, coupled with the need to comply with stringent regulatory requirements, has further fueled the demand for preclinical CRO services. However, the market growth may be restrained by factors such as the high cost of preclinical studies, the limited availability of skilled professionals, and the challenges associated with data security and intellectual property protection. Despite these challenges, the preclinical CRO market presents significant opportunities for growth, driven by the increasing adoption of advanced technologies such as 3D cell culture, organ-on-a-chip, and in silico modeling, which can help improve the predictivity and efficiency of preclinical studies. Moreover, the growing demand for personalized medicine and the increasing focus on rare diseases and orphan drugs are expected to create new opportunities for preclinical CROs in the coming years.

Key Features of the Study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global preclinical CRO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Charles River Laboratories, Covance (Labcorp), WuXi AppTec, ICON plc, PPD (Part of Thermo Fisher Scientific), Medpace, Evotec SE, Syneos Health, BioReliance (Merck KGaA), Charles River, KCR, Parexel International, Inotiv, Toxikon, and Harlan Laboratories
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global preclinical CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preclinical CRO market

Market Segmentation

Service Insights (Revenue, USD Bn, 2021 - 2033)
Bioanalysis and DMPK studies
- In vitro ADME
- In-vivo PK
Toxicology Testing
- GLP
- Non-GLP
Compound Management
- Process R&D
- Custom Synthesis
- Others
Chemistry
- Medicinal Chemistry
- Computation Chemistry
Safety Pharmacology
Others
Type Insights (Revenue, USD Bn, 2021 - 2033)
Patient-Derived Organoid (PDO) Models
Patient-Derived Xenograft (PDX) Models
Animal Model Insights (Revenue, USD Bn, 2021 - 2033)
Small Animal Model
Large Animal Model
Model System Insights (Revenue, USD Bn, 2021 - 2033)
In Vivo
In Vitro
Application Insights (Revenue, USD Bn, 2021 - 2033)
Oncology
Neurology
Cardiology
Infectious Diseases
Metabolic Disorders
Others
End Users Insights (Revenue, USD Bn, 2021 - 2033)
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
Research Institutes and Universities
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Charles River Laboratories
Covance (Labcorp)
WuXi AppTec
ICON plc
PPD (Part of Thermo Fisher Scientific)
Medpace
Evotec SE
Syneos Health
BioReliance (Merck KGaA)
Charles River
KCR
Parexel International
Inotiv
Toxikon
Harlan Laboratories

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Preclinical CRO Market, By Service
- Global Preclinical CRO Market, By Type
- Global Preclinical CRO Market, By Animal Model
- Global Preclinical CRO Market, By Model System
- Global Preclinical CRO Market, By Application
- Global Preclinical CRO Market, By End Users
- Global Preclinical CRO Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Preclinical CRO Market, By Service, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Bioanalysis and DMPK studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - In vitro ADME
  - In-vivo PK
Toxicology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - GLP
  - Non-GLP
Compound Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Process R&D
  - Custom Synthesis
  - Others
Chemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Medicinal Chemistry
  - Computation Chemistry
Safety Pharmacology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Preclinical CRO Market, By Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Patient-Derived Organoid (PDO) Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Patient-Derived Xenograft (PDX) Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Preclinical CRO Market, By Animal Model, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Small Animal Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Large Animal Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Preclinical CRO Market, By Model System, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
In Vivo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
In Vitro
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Preclinical CRO Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Preclinical CRO Market, By End Users, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Government and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Research Institutes and Universities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

10. Global Preclinical CRO Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Model System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Model System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Model System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Model System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Model System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Model System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Covance (Labcorp)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ICON plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PPD (Part of Thermo Fisher Scientific)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medpace
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Evotec SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Syneos Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioReliance (Merck KGaA)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Charles River
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
KCR
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Parexel International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Inotiv
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Toxikon
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Harlan Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies